Matches in SemOpenAlex for { <https://semopenalex.org/work/W2289859189> ?p ?o ?g. }
- W2289859189 endingPage "835" @default.
- W2289859189 startingPage "828" @default.
- W2289859189 abstract "To evaluate the clinical and structural efficacy of tocilizumab (TCZ) during its long-term administration in patients with rheumatoid arthritis (RA).In total, 693 patients with RA who started TCZ therapy were followed for 3 years. Clinical efficacy was evaluated by DAS28-ESR and Boolean remission rates in 544 patients. Joint damage was assessed by calculating the modified total Sharp score (mTSS) in 50 patients.When the reason for discontinuation was limited to inadequate response or adverse events, the 1-, 2-, and 3-year continuation rates were 84.0%, 76.8%, and 72.2%, respectively. The mean DAS28-ESR was initially 5.1 and decreased to 2.5 at 6 months and to 2.2 at 36 months. The Boolean remission rate was initially 0.9% and increased to 21.7% at 6 months and to 32.2% at 36 months. The structural remission rates (ΔmTSS/year ≤ 0.5) were 68.8%, 78.6%, and 88.9% within the first, second, and third years, respectively. The structural remission rate at 3 years (ΔmTSS ≤ 1.5) was 66.0%, and earlier achievement of swollen joint count (SJC) of 1 or less resulted in better outcomes.TCZ was highly efficacious, and bone destruction was strongly prevented. SJC was an easy-to-use indicator of joint destruction." @default.
- W2289859189 created "2016-06-24" @default.
- W2289859189 creator A5000146197 @default.
- W2289859189 creator A5000647160 @default.
- W2289859189 creator A5001665110 @default.
- W2289859189 creator A5002232374 @default.
- W2289859189 creator A5003437546 @default.
- W2289859189 creator A5007245277 @default.
- W2289859189 creator A5007631062 @default.
- W2289859189 creator A5009137789 @default.
- W2289859189 creator A5011022483 @default.
- W2289859189 creator A5013278392 @default.
- W2289859189 creator A5013964702 @default.
- W2289859189 creator A5020066400 @default.
- W2289859189 creator A5020233791 @default.
- W2289859189 creator A5021387749 @default.
- W2289859189 creator A5022986925 @default.
- W2289859189 creator A5026835806 @default.
- W2289859189 creator A5031762822 @default.
- W2289859189 creator A5034949085 @default.
- W2289859189 creator A5035719372 @default.
- W2289859189 creator A5036301657 @default.
- W2289859189 creator A5036465305 @default.
- W2289859189 creator A5037412381 @default.
- W2289859189 creator A5038413661 @default.
- W2289859189 creator A5039966119 @default.
- W2289859189 creator A5042340344 @default.
- W2289859189 creator A5044456241 @default.
- W2289859189 creator A5046347321 @default.
- W2289859189 creator A5049438854 @default.
- W2289859189 creator A5050771781 @default.
- W2289859189 creator A5056129905 @default.
- W2289859189 creator A5058628871 @default.
- W2289859189 creator A5064409870 @default.
- W2289859189 creator A5065592037 @default.
- W2289859189 creator A5068041179 @default.
- W2289859189 creator A5068846354 @default.
- W2289859189 creator A5069249681 @default.
- W2289859189 creator A5071346122 @default.
- W2289859189 creator A5071428569 @default.
- W2289859189 creator A5074488025 @default.
- W2289859189 creator A5078213234 @default.
- W2289859189 creator A5078607790 @default.
- W2289859189 creator A5084089033 @default.
- W2289859189 creator A5085730707 @default.
- W2289859189 creator A5086037608 @default.
- W2289859189 creator A5090428843 @default.
- W2289859189 creator A5091064461 @default.
- W2289859189 date "2016-04-21" @default.
- W2289859189 modified "2023-10-03" @default.
- W2289859189 title "Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group" @default.
- W2289859189 cites W1657590181 @default.
- W2289859189 cites W1997568521 @default.
- W2289859189 cites W2019466258 @default.
- W2289859189 cites W2024272721 @default.
- W2289859189 cites W2028545661 @default.
- W2289859189 cites W2055563250 @default.
- W2289859189 cites W2056545932 @default.
- W2289859189 cites W2075563270 @default.
- W2289859189 cites W2110177517 @default.
- W2289859189 cites W2118561596 @default.
- W2289859189 cites W2130225477 @default.
- W2289859189 cites W2139339400 @default.
- W2289859189 cites W2144621019 @default.
- W2289859189 cites W2150752051 @default.
- W2289859189 cites W2150952126 @default.
- W2289859189 cites W2158733279 @default.
- W2289859189 cites W2325572541 @default.
- W2289859189 cites W2404140462 @default.
- W2289859189 cites W4249063051 @default.
- W2289859189 cites W4253469911 @default.
- W2289859189 doi "https://doi.org/10.3109/14397595.2016.1160991" @default.
- W2289859189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26934116" @default.
- W2289859189 hasPublicationYear "2016" @default.
- W2289859189 type Work @default.
- W2289859189 sameAs 2289859189 @default.
- W2289859189 citedByCount "14" @default.
- W2289859189 countsByYear W22898591892016 @default.
- W2289859189 countsByYear W22898591892017 @default.
- W2289859189 countsByYear W22898591892018 @default.
- W2289859189 countsByYear W22898591892019 @default.
- W2289859189 countsByYear W22898591892020 @default.
- W2289859189 countsByYear W22898591892021 @default.
- W2289859189 countsByYear W22898591892023 @default.
- W2289859189 crossrefType "journal-article" @default.
- W2289859189 hasAuthorship W2289859189A5000146197 @default.
- W2289859189 hasAuthorship W2289859189A5000647160 @default.
- W2289859189 hasAuthorship W2289859189A5001665110 @default.
- W2289859189 hasAuthorship W2289859189A5002232374 @default.
- W2289859189 hasAuthorship W2289859189A5003437546 @default.
- W2289859189 hasAuthorship W2289859189A5007245277 @default.
- W2289859189 hasAuthorship W2289859189A5007631062 @default.
- W2289859189 hasAuthorship W2289859189A5009137789 @default.
- W2289859189 hasAuthorship W2289859189A5011022483 @default.
- W2289859189 hasAuthorship W2289859189A5013278392 @default.
- W2289859189 hasAuthorship W2289859189A5013964702 @default.
- W2289859189 hasAuthorship W2289859189A5020066400 @default.
- W2289859189 hasAuthorship W2289859189A5020233791 @default.